- United States
- /
- Pharma
- /
- NYSE:MRK
Looking At Merck & Co., Inc. (NYSE:MRK) From All Angles
Attractive stocks have exceptional fundamentals. In the case of Merck & Co., Inc. (NYSE:MRK), there's is a well-regarded dividend payer with a strong history of delivering benchmark-beating performance. In the following section, I expand a bit more on these key aspects. For those interested in digging a bit deeper into my commentary, take a look at the report on Merck here.
Solid track record established dividend payer
MRK delivered a triple-digit bottom-line expansion over the past couple of years, with its most recent earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 33%, which is an optimistic signal for the future.
For those seeking income streams from their portfolio, MRK is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 2.6%.
Next Steps:
For Merck, there are three essential factors you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for MRK’s future growth? Take a look at our free research report of analyst consensus for MRK’s outlook.
- Financial Health: Are MRK’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of MRK? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
About NYSE:MRK
Merck
Operates as a healthcare company worldwide.
Undervalued established dividend payer.
Similar Companies
Market Insights
Weekly Picks

An Undervalued 3.3Moz Gold Project in Canada

Hermès - Expensive bags, and expensive stock. And the story of €14 billion of bearer shares gone missing.
Cheniere Energy (LNG) — The Toll Road That Geopolitics Just Made More Valuable
Strong execution in a growing category, but long‑term value hinges on cash‑flow discipline
Recently Updated Narratives

A case for Almadex: conservative CAD 4.50–7.00 (x8–x12) to bull CAD 25–40+ (x42–x68+)

Nebius Group NV (NBIS): The AI Infrastructure Pivot and the Meta Super-Contract

Intel Corp (INTC): The 18A Node Pivot and the "Foundry First" Transformation
Popular Narratives
Nu holdings will continue to disrupt the South American banking market
SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System
